Dr Peter Lin unpacks how SARS CoV 2 uses the ACE2 pathway to turn a respiratory infection into a systemic disease, explaining long COVID, thrombotic events, and severe outcomes in vulnerable patients.
In this Product Explainer, Specialty Primary Care Physician Dr Peter Lin explains how COVID’s pathogenesis is primarily mediated via the ACE2 cell receptor. Dr Lin outlines how antivirals are an essential early treatment for vulnerable patients, and emphasises the importance of advance planning in this context.
What if a “flatter” COVID curve isn’t the good news it seems for your older patients? In this episode, epidemiologist Professor Adrian Esterman challenges some comfortable assumptions about COVID in the elderly and outlines a few simple GP led changes that could make a life saving difference this winter.
An outbreak of the deadly Nipah virus in India has put many countries in Asia on high alert, given the fatality rate in humans can be between 40% and 75%.
H5N1 bird flu has infected growing numbers of people worldwide in recent years, but this week saw something new: the first recorded human case of an H5N5 avian influenza virus. What is this virus and how concerned about it should we be?
In this Product Explainer, Consultant Paediatric Immunologist and Paediatrician Prof Peter Richmond provides an update on the 20vPnC pneumococcal conjugate vaccine including availability and eligibility (4 mins).
In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist Prof Paul Griffin provides an update on the intranasal flu vaccine now available and provides a detailed demonstration of how to use the device (8 mins).
Could nasal saline benefit more patients than you think? In this Product Explainer, Allergist and Medical Rhinologist Dr Jessica Tattersall highlights the supportive role of nasal saline – both with and without the presence of sinonasal pathology – and raises important considerations when recommending nasal saline to patients (5 mins).
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.